Home   About this service   Get the news  
+32 2 743 34 03

 
UCB [BE0003739530 / UCB]

UCB Media Room: Disposals of own shares

INFORMATION REGLEMENTEE


[23/10/2020 | 20:04]
https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513=
9PTmAm2ORJ-2Fb7C-2B6ek1eMC5o4Ob1FB1kW-2BcMmxacDpfP37TJ-2B7kfEDb5wIZkD0p8IrM=
YH4Q8JbkhzhjTfUQfsg7mBl7sN8U0M78R8KU2_Jb_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVW=
u7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9=
g1wYcoYpJJ-2BN3ixk7TDeqvy3o3UetRtCTjIpHZtxGa-2BTdDejm-2FBkxrkPIFHOFH5lLqGat=
6zbVNQG1E-2FmoeBL8KQGAAjnnmn6pTkkezzxFBQwSrjP-2BZdtgZ060UNZ3TofiBnKK2QODtdQ=
YXlqca6JDFXwTljLPOZQLtAoElxjNU30GUaVql0-2FYnbrXiPUNy8m5Bo9U3HxQLQtw-2FxrO9E=
ty1sEEKGcfhVn19-2BnWVWcVafH-2FlWdxRPqgb2JW-2FfWlZ8UJPKs-3D

** Disposals of own shares
------------------------------------------------------------

Brussels (Belgium), 23 October 2020 =E2=80=93 20:00 (CEST) =E2=80=93 regula=
ted information

In accordance with article 8:6 of the Royal Decree executing the Belgian Co=
de of Companies and Associations, UCB SA/NV (=E2=80=9CUCB=E2=80=9D or the =
=E2=80=9CCompany) (Euronext Brussels: UCB) announces that, following exerci=
ses of stock options by members of its personnel, it has disposed of UCB sh=
ares OTC in view of deliveries of these shares to the relevant members of t=
he personnel, within the framework of the Long Term Incentive Program of th=
e UCB Group, as follows:

https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513=
9PTmAm2ORJ-2Fb7C-2B6ek1eMC5o4Ob1FB1kW-2BcMmxa74mnMsakxhc3YOgDCGmH7BSg-2F7D5=
4qs4BEjGuIbGnFyXABfJDZtfAgwGKqe0TH6nN83Z_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVW=
u7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9=
g1wYcoYpJJ-2BN3ixk7TDeqvy3o3UetRtCTjIpHZtxGa-2BTdDejm-2FBkxrkPIFHOFH5lLqGat=
6zbVNQG1E-2FmoeBL8KQGAAjnnmn6pTkkezzxFBQwSrlOqixkd3F7yDOYpWDJUUrPcx9yBAdj6Z=
zBw-2BuvS3yy-2BNs8KEwGc2KjSDRQg3zX8yROwC98WX5LH34rZtmlJgsY86P4DUqBQvy7Ihzch=
-2BQhb8RV7n95q9VuU79V02C5001LWtxdSX7sbbVczWls1-2Bic-3D

This press release is available on UCB SA/NV=E2=80=99s website via the foll=
owing link (https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQ=
yQ53jATUXZJD59ZUodhGC-2FyJVE-2BjXw-2Fd0j1C70r-2FZ058zOLCiGbx-2FzvKhSzxYKNx1=
8dK5MiuQ-3D-3DRiJi_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bS=
l0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wYcoYpJJ-2BN3ixk7TDe=
qvy3o3UetRtCTjIpHZtxGa-2BTdDejm-2FBkxrkPIFHOFH5lLqGat6zbVNQG1E-2FmoeBL8KQGA=
Ajnnmn6pTkkezzxFBQwSrrv2kuuYtF-2B3mTdMeCUy6epZNWzJGkaR4XGHi0dEH0mQH68xBmUmg=
NG9CVEP1KF-2B9ur-2FV-2BIH5FUrqknqqRTxwiKPMm6w7fSxEvxnFauU57Nuy0mo3VPP8XgWnt=
5QSpImvTZxSyfKs-2B5qm7ptdO1y2EI-3D .
=C2=A0
Investor Relations

Antje Witte =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0
Investor Relations, UCB
T +32.2.559.94.14 antje.witte@ucb.com

Isabelle Ghellynck,
=C2=A0Investor Relations, UCB
T+32.2.559.9588, isabelle.ghellynck@ucb.com=C2=A0

About UCB
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company =
focused on the discovery and development of innovative medicines and soluti=
ons to transform the lives of people living with severe diseases of the imm=
une system or of the central nervous system. With 7 500 people in approxima=
tely 40 countries, the company generated revenue of =E2=82=AC 4.9 billion i=
n 2019. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twit=
ter: @UCB_news
=C2=A0
GenericFile
201023 - Vervreemding van eigen aandelen (https://u7061146.ct.sendgrid.net/=
ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6ek1eMC5o4Ob1F=
B1kW-2BcMmxahOArMGHQqPExlZ7Mwff8nUAFlqzoS2U22SFLOkBxqF4-3DpSLv_xDPID0vOuylF=
AU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2=
FOeoCOG9ekocVj-2F2X9c9g1wYcoYpJJ-2BN3ixk7TDeqvy3o3UetRtCTjIpHZtxGa-2BTdDejm=
-2FBkxrkPIFHOFH5lLqGat6zbVNQG1E-2FmoeBL8KQGAAjnnmn6pTkkezzxFBQwSru18N4S8gGj=
raUrkeO9Y7vqmqSP8ziM-2BNgs02bwi-2Fipe3Pid1r8F7bmKwsr-2BVLtdL9oDuMn0qxgTYQj-=
2Bv2N85-2BFvaP8KYs80RgIDJmof1wHo2TZlPxkcwCfGy5MdulSv3arrJ39NI2Y9L6vkcDNlBzA=
-3D GenericFile
201023 - Ali=C3=A9nation d actions propres (https://u7061146.ct.sendgrid.ne=
t/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6ek1eMC5o4Ob=
1FB1kW-2BcMmxataSwRmG4bKQQQNa1u4c8M3SB14-2FqmRvvxiroQ4u38eg-3DEnKJ_xDPID0vO=
uylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Z=
lf-2FOeoCOG9ekocVj-2F2X9c9g1wYcoYpJJ-2BN3ixk7TDeqvy3o3UetRtCTjIpHZtxGa-2BTd=
Dejm-2FBkxrkPIFHOFH5lLqGat6zbVNQG1E-2FmoeBL8KQGAAjnnmn6pTkkezzxFBQwSrvQ68AT=
4lSg7QWgxUo9a6NWk-2BL42-2F2kLT-2BZtDL2Seeml6tcs4DgYSUsMrd7hCetFyHjgqR61PyYf=
5SPcz-2F0Mt-2Fntm624ZxspILYXa1jcCMqYatUJkPUqWY-2FPugVWO-2FcUXCW3lYunJO9Lob9=
4clx-2B7E4-3D GenericFile
201023 - Disposals of own shares (https://u7061146.ct.sendgrid.net/ls/click=
?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6ek1eMC5o4Ob1FB1kW-2Bc=
Mmxab1Qqeyxx1e4IG39b9PclTyB3nU78Vd6rtXBFpw1jR3E-3Dxpyd_xDPID0vOuylFAU8fv4e6=
0wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9=
ekocVj-2F2X9c9g1wYcoYpJJ-2BN3ixk7TDeqvy3o3UetRtCTjIpHZtxGa-2BTdDejm-2FBkxrk=
PIFHOFH5lLqGat6zbVNQG1E-2FmoeBL8KQGAAjnnmn6pTkkezzxFBQwSrlh9fafU-2FKzFdTFfw=
Uyrtf48IGuFxOBOi2Y-2BHwuHvUKLlULKkgie9J6zeRezWazqHWRT6-2BgGxwtvHBp79D5Ia9Cz=
bJ09K-2Bsdmft2NgjE-2Bk5s9txB5lSaxlg4xdQp9g1K-2Fa5UeOZV2pUOPRJcOlJMZBs-3D Im=
age
Chart 1 Oct 23 2020 (https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-=
2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6ek1eMC5o4Ob1FB1kW-2BcMmxa74mnMsakx=
hc3YOgDCGmH7NlyqcZDvSBqzC8rOkTs79A-3DNOM4_xDPID0vOuylFAU8fv4e60wei4JxqEGBdV=
Wu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c=
9g1wYcoYpJJ-2BN3ixk7TDeqvy3o3UetRtCTjIpHZtxGa-2BTdDejm-2FBkxrkPIFHOFH5lLqGa=
t6zbVNQG1E-2FmoeBL8KQGAAjnnmn6pTkkezzxFBQwSrj0ATNyjTe58YCXgB9g5Kly43EiRpoGo=
xM5LMWqI0Cvb-2FCBXhI5QoViSMYNVtLR6umOU1eOIgXjymbq-2FGoTlS6tmD1fJz8yY4dg4-2F=
-2Fw9IPxEkWZVbyBk-2BDT20aFlZV6PWMNAeBMFhZVy2ePqlPImE44-3D=0D
=0D
______________________=0D
If you would rather not receive future communications from UCB SA, please g=
o to https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jAT=
UeYfdhr1xEBQnaPhR2RKx1tfe2VKDZTewv5u80JomRcXE3XxGo5QpSeItRvIQyoX9F1-2BnbraQ=
wg8KV4vq2IiejsZPNMhNkF02wHkB8l-2B2wMURpg5Pp1KlJdF2GBP9HzBgUJuBs-2FahNoaO2CF=
ncnEF4g-3Dbijp_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0Kx=
vPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wYcoYpJJ-2BN3ixk7TDeqvy3=
o3UetRtCTjIpHZtxGa-2BTdDejm-2FBkxrkPIFHOFH5lLqGat6zbVNQG1E-2FmoeBL8KQGAAjnn=
mn6pTkkezzxFBQwSrs8b3v5qwTt2buTqwwF7aAofYW-2FqhY7KFM7J5VGD5-2FgbzfHdwYYmzlZ=
OA4AFSKzTeMaAf1a2PKKF6VsQJio0A3lcdEKTRo-2FvckWtbu2MoDf2Tuo-2FFxHS93-2FeemNB=
kx0OAaqsgGTMWcRzVskR50LMDjU-3D=0D
UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium=